13th World Congress on Virology and Infectious diseases

Indranil Banerjee Assistant Professor^*
*Correspondence: Indranil Banerjee, Assistant Professor, Indian Institute of Science Education and Research, India, Email:

Virology Asia Pacific 2019 welcomes attendees, presenters, and exhibitors from all over the world to Tokyo, Japan. We are delighted to invite you all to attend and register for the “13th World Congress on Virology and Infectious diseases” which is going to be held during February 24-25, 2020 at Tokyo, Japan. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Virology Asia 2020, where you will be sure to have a meaningful experience with scholars from around the world. All the members of Virology Asia 2020 organizing committee look forward to meet you at Tokyo, Japan.

In the new bio economy, Virus and Infectious disease play a very important role in addressing major global challenges, being instrumental for improved resource efficiency, making renewable substitutes for products from fossil resources, upgrading waste streams to valuable food and feed ingredients, counteracting life-style diseases and antibiotic resistance through strengthening the gut biota, making crop plants more robust to survive climate change conditions, and functioning as host organisms for production of new biological drugs.

This range of new uses of virus and Infectious diseases all stand on the shoulders of the efforts of virologists and Scientists over generations: the scientific discipline virology and Infectious diseases has built comprehensive understanding within viral, Bacterial, Parasitic and fungal biodiversity, classification, evolution, genetics, physiology, ecology, pathogenesis, and nutrition. Applied Virology and Infectious disease could not make progress without this platform. To unfold the full potentials of what virus and fungi can do for both environment and man we need to strengthen the field of virology and Infectious diseases on a global scale. In Virology Market Asia Pacific is projected to have the fastest growth, owing to a rapidly developing medical infrastructure, increasing spending on healthcare and growing medical tourism in developing nations such as China and India in this region. The generic competition in the virology market will be at a high pace 2019 onward. In 2018 the global cancer immunotherapies market had extended to $73.0 billion. In 2021 it is expected that this market will progress to nearly about $96.5 billion over the period of 5 years with a compound annual growth rate (CAGR) of 5.7% from 2016 to 2021.

Top most Universities doing research on Virology and Infectious diseases

• Osaka University, Japan

• Harvard university, United States

• Kyoto University, Japan

• University of Adelaide, Australia

• University of oxford, United Kingdom

• Zhejiang University, China

• McGill University, Canada

• National university of Singapore, Singapore

• University of Chicago, United States

• University of Tokyo, Japan

Association and Society

• American Society for Virology

• Pan-American Society for Clinical Virology

• European Society for Virology

• European Society for Clinical Virology

• International Retroviology Association

• North American Mycological Association

• The British Mycological Society

• IIIinois Mycological Association

• New York Mycological Society

• Puget sound Mycological Society

• Mycological Society of Toronto

Pharmaceutical Companies

• Alios Biopharma

• Bayer

• AstraZeneca

• Merck

• Sanofi

• Gilead Sciences

• Roche

• Novartis

• Johnson & Johnson

• ICM Pharma Pte. Ltd.

• Beacons Pharmaceutical pte. Ltd

• Aventis Pharma

• Pfizer Private Limited